ReviewNeurology2025
Statistical Practice of Ordinal Outcome Analysis in Neurologic Trials: A Literature Review.
Review in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A Meta-epidemiologic Analysis of Differences in Treatment-Effect Estimates According to Outcome Scale (GOS vs. GOSE) in Moderate-to-Severe Traumatic Brain Injury Trials.Neurocritical care · 2026Article
- Longitudinal Extension of the Win Odds for Ordinal Repeated Measurements.Statistics in medicine · 2026Article
- Applicability of Regression Models for the Analysis of Ordinal PANSS Data in Schizophrenia: A Cohort Study.Consortium psychiatricum · 2026Article
- Role of the Proportional Odds Assumption for the Analysis of Ordinal Outcomes in Neurologic Trials.Neurology · 2025Article
- Statistical Practice of Ordinal Outcome Analysis in Neurologic Trials: A Literature Review.Neurology · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesOrdinal scales are widely adopted as outcome measures in neurologic randomized controlled trials (RCTs). We aimed to evaluate which statistical methods have been used to test and estimate treatment effects from ordinal outcomes in recent RCTs across a range of acute neurologic diseases.
methodsWe searched PubMed for RCTs in 5 acute monophasic neurologic diseases (stroke, traumatic brain injury [TBI], subarachnoid hemorrhage [SAH], meningitis, and Guillain-Barré syndrome [GBS]) published in high-impact journals between January 1, 2015, and November 1, 2023. Trials had to report on an ordinal scale as the primary or secondary efficacy outcome. Two independent reviewers performed study screening and data extraction. We evaluated the results to determine how investigators (1) addressed the ordinal nature of outcomes, (2) assessed and reported key assumptions, (3) used longitudinal measurements, and (4) adjusted for prognostic covariates.
resultsWe reviewed 70 RCTs for treatment evaluations in stroke (n = 36), TBI (n = 13), SAH (n = 10), meningitis (n = 7), and GBS (n = 4). In 46 of 70 trials (66%), investigators retained the full ordering information, commonly analyzed using a proportional odds model (33/46 trials, 72%). The proportional odds assumption was not addressed in 23 of 33 trials (62%). In 22 of 70 trials (31%), the ordinal outcome was dichotomized, with notable variation in the cut-point for each ordinal scale. In 41 of 70 trials (59%), the ordinal outcome was assessed at multiple time points while some form of longitudinal data analysis was performed in only 3 of these 41 studies (7%). The time point chosen for analysis varied within neurologic conditions. Covariate adjustment was reported in 48 of 70 studies (69%). DISCUSSION: There is a large variation in the current practice of analyzing ordinal outcomes in neurologic trials. Dichotomization and focus on a single time point are common; therefore, information contained in the rank ordering of the outcome and repeated measurements is not fully used. Further research needs to clarify the balance between maximizing the statistical power, making assumptions, and allowing for straightforward interpretations in approaches that make more effective use of the outcome data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.